Micronesia (country) vs Nauru: The number of people with susceptibility test result for rifampicin
Micronesia (country)
100
in 2021
Nauru
100
in 2021
Micronesia (country) rank
2nd
Nauru rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Micronesia (country)
- Nauru
How they compare
Micronesia (country) currently reports 100 against 100 in Nauru, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Micronesia (country) ahead.
Micronesia (country) ranks 2nd and Nauru ranks 2nd of 146 countries.
Micronesia (country) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Micronesia (country) | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 108.78 | 0 | 108.78 | Micronesia (country) |
| 2020s | 100 | 50 | 50 | Micronesia (country) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Micronesia (country) or Nauru?
- Micronesia (country), at 100 against 100 in Nauru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Micronesia (country) and Nauru?
- 0, with Micronesia (country) ahead.
- How many years of comparable data are there for Micronesia (country) and Nauru?
- 5 years are reported by both, from 2017 to 2021.
- How do Micronesia (country) and Nauru rank globally for the number of people with susceptibility test result for rifampicin?
- Micronesia (country) ranks 2nd and Nauru ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.